The Immunological Impact of Adding Hydroxychloroquine in Patients With Discordant CD4+ Cell Responses to Suppressive HAART: A Phase I Pilot Study.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Antiretrovirals; Hydroxychloroquine
- Indications HIV infections
- Focus Pharmacodynamics
- 11 Feb 2014 Biomarkers information updated
- 08 Dec 2011 Planned end date changed from 1 Aug 2011 to 1 Aug 2012 as reported by ClinicalTrials.gov.
- 01 Apr 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.